Recent News

Oriental hornets can drink unlimited amounts of alcohol without damage

A new study from Tel Aviv University (TAU) has revealed that the Oriental hornet is the only animal in nature capable of consuming alcohol chronically and in high concentrations with almost no negative effects on their health or lifespan. The research team says, “This is a remarkable animal that shows no signs of intoxication or… Read More

TAU ranks #7 globally and #1 outside the USA for global entrepreneurship

Tel Aviv University (TAU) continues to lead in global entrepreneurship, ranking #7 worldwide and #1 outside the USA in the 2024 Pitchbook Ranking. The achievement is driven by 893 TAU alumni with bachelor’s degrees, who have founded 755 companies over the past decade, raising an impressive $29.8 billion in total capital. The annual Pitchbook Ranking,… Read More

AFTAU receives $1 million impact gift from David Magerman and The Tzemach David Foundation

Philanthropist David Magerman, through The Tzemach David Foundation, has made a $1,000,000 five-year investment in Tel Aviv University (TAU). This new funding will initially support a program for non-Hebrew speaking students to learn academic Hebrew and integrate into STEM degree programs. Magerman, a data scientist and venture capitalist, publicly pulled his donations from the University… Read More

TAU research finds antibiotics and laxatives in corals at a depth of 40 meters

A new study from Tel Aviv University (TAU) and the Steinhardt Museum of Natural History at the university detected traces of ten common medications in coral samples collected from both shallow and deep sites in the Gulf of Eilat. Sulfamethoxazole, an antibiotic used for respiratory and urinary tract infections, was found in as many as… Read More

Changes in the chromosomes of cancer cells may increase their sensitivity to anti-cancer drugs

Two complementary studies from the Faculty of Medical and Health Sciences at Tel Aviv University (TAU), in collaboration with the European Institute of Oncology in Milan, have extensively examined the characteristics of aneuploid cells, which have an abnormal number of chromosomes, and raised findings that may advance new cancer treatments. According to the researchers, “A… Read More

New TAU technology may enable early diagnosis of Parkinson’s disease

Researchers at Tel Aviv University (TAU) in cooperation with three major Israeli medical centers have developed a new method for detecting protein aggregation in cells, a hallmark of Parkinson’s disease. The technology can enable diagnosis up to 20 years before the first motor symptoms appear, facilitating treatment or even prevention of the severe disease, which… Read More